Skip to main content

Advertisement

SpringerLink
Log in

Radiopacity of sodium zirconium cyclosilicate on CT imaging

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

A patient who post-operatively develops hyperkalemia is treated with sodium zirconium cyclosilicate (Lokelma®), a novel agent used for the treatment of non-life-threatening hyperkalemia with reduced side effects as compared with its predecessors. On CT imaging of the chest, abdomen, and pelvis, a radiopaque fluid is noticed despite the patient not having received any oral or intravenous contrast nor any medications or supplements that may appear radiopaque. Based on previous CT imaging of zirconium-based tooth implants and their radiopaque appearance on images, it is hypothesized that the sodium zirconium cyclosilicate that the patient was administered is the explanation of the radiopacity on CT imaging. We performed an in-vitro experiment to confirm that Lokelma is radiopaque to support our hypothesis. It is important to fully understand the differential of what may cause different appearances on imaging as well as to eliminate potential sources of artifact prior to imaging, or alternatively, to potentially be able to use medications with known radiopaque properties as alternatives to contrast agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Savitt DL, Hawkins HH, Roberts JR. The radiopacity of ingested medications. Ann Emerg Med. 1987;16(3):331–9.

    Article  CAS  Google Scholar 

  2. Hoy SM. Sodium zirconium cyclosilicate: a review in hyperkalaemia. Drugs. 2018;78(15):1605–13.

    Article  CAS  Google Scholar 

  3. Sodium zirconium cyclosilicate (2018) In European Medicines Agency [database on the internet]. European Medicines Agency, Amsterdam, Netherlands [updated 07/05/2020, cited 15/2/2021]

  4. McCarney B, Binkley N, Krueger D (2020) A newly recognized DXA confounder: the potassium-binding medication sodium zirconium cyclosilicate. J Clin Densitom 21:S1094-6950(20)30089-5. Epub ahead of print

  5. Smeets R, Schöllchen M, Gauer T, Aarabi G, Assaf AT, Rendenbach C, et al. Artefacts in multimodal imaging of titanium, zirconium and binary titanium–zirconium alloy dental implants: an in vitro study. Dentomaxillofac Radiol. 2017;46(2):20160267.

    Article  Google Scholar 

  6. Fontenele RC, Nascimento EH, Vasconcelos TV, Noujeim M, Freitas DQ. Magnitude of cone beam CT image artifacts related to zirconium and titanium implants: impact on image quality. Dentomaxillofac Radiol. 2018;47(6):20180021.

    Article  Google Scholar 

  7. Kaplan M, Ozeri Y, Agranat A, Brisk R, Eylath U. Antacid bezoar in a premature infant. Am J Perinatol. 1995;12(2):98–9.

    Article  CAS  Google Scholar 

  8. Iwamuro M, Saito S, Yoshioka M, Urata H, Ueda K, Yamamoto K, Okada H. A magnesium oxide bezoar. Intern Med. 2018;57(21):3087–91.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St John’s Riverside Hospital, 967 North Broadway, Yonkers, NY, 10701, USA

    Michael Kolesnik, David Berezovsky, Martin Sayegh & Majed Samarneh

Authors
  1. Michael Kolesnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Berezovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Sayegh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Majed Samarneh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Kolesnik.

Ethics declarations

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kolesnik, M., Berezovsky, D., Sayegh, M. et al. Radiopacity of sodium zirconium cyclosilicate on CT imaging. CEN Case Rep 10, 559–562 (2021). https://doi.org/10.1007/s13730-021-00607-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-021-00607-9

Keywords

Search

Navigation